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Abstract
Objective: To verify the effectiveness of noninvasive ventilation 
compared to conventional physiotherapy or oxygen therapy in 
the mortality rate and prevention of pulmonary complications 
in patients during the immediate postoperative period of cardiac 
surgery. 
Methods: Systematic review and meta-analysis recorded in 
the International Prospective Register of Ongoing Systematic 
Reviews (number CRD42016036441). The research included the 
following databases: MEDLINE, Cochrane Central, PEDro, LILACS 
and manual search of the references of studies published until 
March 2016. The review included randomized controlled trials with 
patients during the immediate postoperative period of cardiac 
surgery, which compared the use of noninvasive ventilation, 
BiLevel modes, continuous positive airway pressure, intermittent 
positive pressure breathing and positive pressure ventilation with 
conventional physiotherapy or oxygen therapy, and assessed the 
mortality rate, occurrence of pulmonary complications (atelectasis, 
pneumonia, acute respiratory failure, hypoxemia), reintubation 
rate, ventilation time, time spent in the intensive care unit (ICU), 
length of hospital stay and partial pressure of oxygen. 
Results: Among the 479 selected articles, ten were included 
in the systematic review (n=1050 patients) and six in the meta-
analysis. The use of noninvasive ventilation did not significantly 
reduce the risk for atelectasis (RR: 0.60; CI95% 0.28-1.28); 
pneumonia (RR: 0.20; CI95% 0.04-1.16), reintubation rate (RR: 0.51; 
CI95%: 0.15-1.66), and time spent in the ICU (-0.04 days; CI95%: 
-0.13; 0.05). 
Conclusion: Prophylactic noninvasive ventilation did not 
significantly reduce the occurrence of pulmonary complications 
such as atelectasis, pneumonia, reintubation rate and time spent in 
the ICU. The use is still unproven and new randomized controlled 
trials should be carried out.
Keywords: Thoracic Surgery. Cardiovascular Surgical Procedures. 
Noninvasive Ventilation. Meta-Analysis.
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Abbreviations, acronyms & symbols
ARF
CABG
CP
CPAP
CPB
ICU
IPPB
 = Acute respiratory failure 
 = Coronary artery bypass grafting
 = Conventional physiotherapy 
 = Continuous positive airway pressure
 = Cardiopulmonary bypass
 = Intensive care unit 
 = Intermittent positive pressure breathing
IS
NIV
PaO2
PO
PSV
RCTs
 = Incentive spirometer 
 = Noninvasive ventilation 
 = Partial pressure of oxygen 
 = Postoperative 
 = Positive pressure ventilation
 = Randomized controlled trials
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INTRODUCTION
Patients in the postoperative (PO) period of cardiac surgery 
have greater risk to develop pulmonary complications. These 
complications can increase hospitalization time, morbidity, 
mortality, and costs for the health system[1]. Among the most 
frequent pulmonary complications are atelectasis, pneumonia, 
pulmonary edema and acute respiratory failure (ARF). Atelectasis 
is one of the most common[1,2].
The etiology of pulmonary complications results from 
a multifactorial process. Surgical factors such as the use of 
cardiopulmonary bypass (CPB), anesthesia, surgery time, 
mechanical ventilation time, pleural opening, phrenic 
nerve alteration, use of the mammary artery in myocardial 
revascularization surgery, pain in the sternal surgical wound and 
in the surgical drains lead to a decrease in the functional residual 
capacity and increase of intrapulmonary shunt[3-6]. In addition, 
preoperative factors regarding the patient, such as previously 
existing lung diseases, smoking, old age, poor nutritional health, 
among others, are a predisposition to complications[7].
Certain measures are used during the PO of cardiac surgeries, 
in an attempt to minimize pulmonary complications, such as 
adequate analgesia, oxygen therapy and physiotherapy. The 
physiotherapist uses the resources and chest physiotherapy 
techniques, such as deep breathing stimulation, cough 
stimulation, use of incentive spirometers, early patient 
mobilization and ambulation[1,8]. However, sometimes these 
features and techniques are not enough, and additional 
measures, such as the use of noninvasive ventilation (NIV), are 
necessary.
NIV is a support for spontaneous ventilation with portable 
ventilators. Its use as a prophylactic measure aims to reduce the 
incidence of endotracheal intubation, length of hospital stay 
and prevent pulmonary complications[9,10]. However, even with 
randomized controlled trials (RCTs) and a systematic review, 
there is no consensus in the literature regarding its use as a 
prophylactic measure after cardiac surgery. 
Zarbock et al.[10] carried out a study with 468 elective heart 
surgery patients during the period of postoperative care and 
showed that the use of prophylactic continuous positive 
airway pressure (CPAP) reduced the incidence of pulmonary 
complications such as hypoxemia, pneumonia, reintubation rate, 
and reduced the readmission rate in intensive care, compared 
to the control group. However, another study with 30 patients 
undergoing coronary artery bypass grafting (CABG) showed 
that CPAP therapy minimized the decrease in partial pressure of 
oxygen (PaO2) after extubation, however, it was unable to prevent 
the decrease of oxygenation on the second PO day[11]. In 2011, 
a systematic review investigated the use of NIV as a preventive 
measure in patients undergoing heart surgery, including four 
studies. The authors found that NIV, compared to standard 
treatment with oxygen therapy and chest physiotherapy, 
significantly improved gas exchange without any significant 
difference in the rate of atelectasis[1].
Thus, the existence of new RCTs related to the prophylactic 
use of NIV in patients during the immediate PO period of cardiac 
surgery, and the absence of meta-analysis, justify a systematic 
review with a recent meta-analysis on the subject. Thus, the 
objective of this review is to verify the effectiveness of the use 
of NIV compared to conventional physiotherapy (CP) or oxygen 
therapy in the mortality rate and prevention of pulmonary 
complications in patients in the immediate PO of cardiac surgery. 
METHODS
This is a systematic review and meta-analysis of RCTs, 
registered with the International Prospective Register of 
Ongoing Systematic Reviews (PROSPERO) under the number 
CRD42016036441, and following the recommendations of 
the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses: The PRISMA Statement[12] and the Cochrane 
Collaboration[13].
Eligibility Criteria
The review included RCTs with patients during the 
immediate PO period of heart surgery (CABG, valve replacement, 
among others) that compared the use of NIV, BiLevel, CPAP, 
intermittent positive pressure breathing (IPPB) and positive 
pressure ventilation (PSV) with CP or oxygen therapy. And 
also, that assessed mortality rate and incidence of pulmonary 
complications (atelectasis, pneumonia, ARF, hypoxemia) as 
primary outcomes, and reintubation rate, ventilation time, time 
spent in the intensive care unit (ICU), length of hospital stay and 
PaO2 as secondary outcomes. Studies that included patients in 
the PO period of other types of surgery, and patients who were 
heart transplant recipients, were excluded from the review.
Search Strategy
The studies were found using a systematic search in the 
databases MEDLINE (via PubMed), Cochrane Central, PEDro, 
LILACS, in addition to a manual search of the references of 
published studies on the subject. There was no restriction 
of date and language for this research. The search included 
studies published from the start of the databases until March, 
2016, and comprised the key descriptors and synonyms terms 
referring to "cardiac surgery", "coronary artery bypass", "tricuspid 
valve replacement", "mitral valve replacement", "aortic valve 
replacement", "noninvasive ventilation", "continuous positive 
airway pressure", and "positive-pressure respiration", combined 
with a sensitive list of ECR search terms developed by Robinson 
& Dickersin[14]. The complete search strategy used for PubMed is 
shown on Table 1. Other strategies will be available upon request.
Study Selection 
Two assessors (S.M.P and A.F.M) independently analyzed 
the titles and abstracts of the articles identified by the search 
strategy, strictly adhering to the inclusion and exclusion criteria. 
Articles that did not provide enough information in the titles and 
abstracts, were fully read by the same assessors, independently. 
The selection was made following the eligibility criteria. 
Disagreements over the inclusion of the studies were resolved 
by consensus among the assessors.
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Table 1. Research strategy used on PubMed.
#1 “Cardiac Surgery”[MeSH] OR “Cardiac Surgery” OR “Surgery, Thoracic” OR “Surgery, Cardiac” OR “Surgery, Heart” OR “Heart 
Surgery” OR “Procedure, Cardiac Surgical” OR “Procedures, Cardiac Surgical” OR “Surgical Procedure, Cardiac” OR “Surgical 
Procedures, Cardiac” OR “Surgical Procedures, Heart” OR “Cardiac Surgical Procedure” OR “Heart Surgical Procedures” OR 
“Procedure, Heart Surgical” OR “Procedures, Heart Surgical” OR “Surgical Procedure, Heart” OR “Heart Surgical Procedure”
#2 “Coronary Artery Bypass”[Mesh] OR “Coronary Artery Bypass” OR “Artery Bypass, Coronary” OR “Artery Bypasses, Coronary” 
OR “Bypasses, Coronary Artery” OR “Coronary Artery Bypasses” OR “Coronary Artery Bypass Surgery” OR “Bypass, Coronary 
Artery” OR “Aortocoronary Bypass” OR “Aortocoronary Bypasses” OR “Bypass, Aortocoronary” OR “Bypasses, Aortocoronary” 
OR “Bypass Surgery, Coronary Artery” OR “Coronary Artery Bypass Grafting” 
#3 “Tricuspid Valve Replacement” OR “Tricuspid Valve Surgery” OR “Valve     Replacement” OR “Valve Surgery” OR “Mitral Valve 
Replacement” OR “Mitral Valve Surgery” OR “Aortic Valve Replacement” OR “Aortic Valve Surgery”
#4    #1 OR #2 OR #3
#5 “Noninvasive ventilation”[MeSH] OR “Noninvasive Ventilation” OR  “Noninvasive Ventilations” OR “Ventilation, Noninvasive” 
OR “Ventilations,     Noninvasive” OR “Non-Invasive Ventilation” OR “Non-Invasive Ventilations”   OR “Ventilation, Non-Invasive” 
OR “Ventilations, Non-Invasive” OR “Non   Invasive Ventilation” OR “Non Invasive Ventilations” OR “Ventilation, Non Invasive” 
OR “Ventilations, Non Invasive” OR “bilevel ventilation” OR  “Noninvasive Positive Pressure Ventilation” OR “CPAP” OR “BIPAP”
 #6 “Continuous Positive Airway Pressure”[Mesh] OR “Continuous Positive  Airway Pressure” OR “CPAP Ventilation” OR “Ventilation, 
CPAP” OR “Biphasic Continuous Positive Airway Pressure” OR “Bilevel Continuous Positive Airway Pressure” OR “Nasal 
Continuous Positive Airway Pressure” OR “Ncpap Ventilation” OR “Ventilation, ncpap” 
#7   “Positive-Pressure Respiration”[Mesh] OR “Positive-Pressure Respiration
#8   #5 OR #6 OR #7 
#9  (randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized controlled trials[mh] OR random allocation[mh] 
OR double-blind method[mh] OR single-blind method[mh] OR clinical trial[pt] OR clinical trials[mh] OR (“clinical trial”[tw]) 
OR ((single*[tw] OR double*[tw] OR OR triple*[tw]) AND (mask*[tw] OR blind*[tw])) OR (&quot;latin square&quot;[tw]) OR 
placebos[mh] OR placebo*[tw] OR random*[tw] OR research design[mh:noexp] OR follow-up studies[mh] OR prospective 
studies[mh] OR cross-over studies[mh] OR control*[tw] OR prospective*[tw] OR volunteer*[tw]) NOT (animal[mh] NOT 
human[mh])
#10  #4 AND #8 AND #9
Data Extraction
The data extraction was performed independently by the 
same two assessors, using a standardized form. Information 
on patient characteristics, intervention, outcomes, and 
methodological quality were extracted. Disagreements were 
resolved by consensus. The main outcomes were mortality 
rate and incidence of pulmonary complications (atelectasis, 
pneumonia, ARF, hypoxemia) and the secondary outcomes were 
reintubation rate, ventilation time (hours), time spent in the ICU, 
length of hospital stay (days), and PaO2. 
Risk of Bias Assessment 
The methodological quality was evaluated independently 
by the same two assessors, in a descriptive manner, based on 
the recommendations of the Cochrane Collaboration[13]. The 
following items were evaluated: random sequence generation, 
allocation concealment, patient blinding, blinding of therapists 
and outcome assessors, intention-to-treat analysis, and 
description of losses and exclusions. These characteristics were 
considered as “not informed” in studies without clear description 
of them.
Data Analysis 
The data analysis was performed in a descriptive and 
quantitative manner. Regarding the categorical outcomes, 
relative risk and 95% confidence intervals were calculated using 
the random effect model (Mantel-Haenszel) according to the 
number of events reported in the intention-to-treat analysis of 
the original studies. For the continuous outcomes, the effect 
estimations were obtained by the difference between the 
averages and their standard deviations, with 95% confidence 
intervals using the random effect model. The statistical 
heterogeneity of the treatment effects between studies was 
assessed using the I-square inconsistency test, where values 
above 25% and 50% were considered as indicative of moderate 
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and high heterogeneity, respectively. All analyses were carried 
out using the Review Manager software, version 5.3 (Cochrane 
Collaboration). 
RESULTS 
Description of the Studies
Four hundred and seventy-nine articles were identified 
with the search strategy, of which 21 studies were considered 
for detailed analysis. After the analysis, ten articles met the 
eligibility criteria and were included in this review, with a total 
of 1050 patients. Among these studies, three used the BiLevel 
mode[8,15,16], four the CPAP[10,11,17,18], one the BiLevel mode and 
CPAP in the same study[3], one the IPPB[19] and one the PSV[20]. 
Regarding the control groups, seven studies[3,10,15-19] performed 
CP. Of these, one performed only CP[16]; the other used CP 
associated with incentive spirometer (IS)[3,19], standard treatment 
(oxygen therapy and CPAP for some patients, pharmacological 
treatment)[10], usual care (pharmacological measures and IS)
[15] and oxygen therapy[17,18]. Two studies[8,11] received oxygen 
therapy exclusively and one of the studies[20] did not clearly 
describe the comparison. Figure 1 shows the flowchart of the 
included studies and Table 2 the characteristics of these studies.
Risk of Bias
Of all the studies included in the systematic review, 30% 
described the random sequence generation[8,15,17], 10% described 
allocation concealment[15]; none of the studies described blinding 
of the therapist and the patient, or presented this information; 
40% of the studies described blindness of the outcome 
assessors, but for only one outcome in each study[3,15,17,19]. All 
studies described the losses and exclusions[3,8,10,11,15-20], and 60% 
described the intention-to-treat analysis[8,10,11,16,18,19] (Table 3).
Intervention Effect
Mortality rate
Only one study (n=126) assessed the mortality rate. The 
authors compared the use of NIV associated with usual care 
(chest physiotherapy, bronchodilator and saline nebulization, 
cough exercises, mobilization and IS) vs. usual care. The mortality 
rate was the same in both groups (1.6%)[15]. 
Fig. 1 – Flowchart of the studies included in the systematic review and meta-analysis. NIV=noninvasive ventilation. PO=postoperative
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Table 2. Characteristics of the studies included in the review.
Study, year Type of surgery
Participants 
(N – I/C)
Intervention 
vs. control 
groups
Intervention 
group
Control 
group
Assessed 
outcomes
Results
Al Jaaly et 
al.[15], 2013 
CABG 126 - 63/63 BiLevel+ usual 
carea, vs. usual 
carea + CPAP 
for six patients 
who needed 
ventilation 
support
Stratified by BMI: 
BMI<30: IPAP 12 
cmH2O, EPAP 5 
cmH2O; BMI≥30: 
IPAP 17, EPAP 10 
cmH2O; for 24h 
(removed so the 
patient could 
eat, or before if 
they could not 
tolerate it)
2x/day on 
the first two 
to three 
days after 
surgery
Mortality rate
Atelectasis
Pneumonia
Reintubation rate
MV Time
Time spent in 
the ICU
Length of 
hospital stay until 
release
Mortality rate: the same in both 
groups
Atelectasis, pneumonia and 
Reintubation rate: less frequent 
in the intervention group
MV Time: similar between groups 
(without statistically significant 
data)
Time spent in the ICU: shorter 
in the intervention group, but 
without significant difference        
(P=0.306) between groups. 
Length of hospital stay 
until release: shorter in the 
intervention group, with 
significant difference (P=0.019) 
between groups, if the medical 
release is considered; and 
similar between groups, without 
significant difference (P=0.552) 
between groups, if non-medical 
factors are considered
Franco et 
al.[16], 2011 
CABG 26 - 13/13 BiLevel+ CPb 
vs. CP
IPAP: 8 to 12 
cmH2O; EPAP: 6 
cmH2O, 2x/day 
for 30 minutes
2x/day, 2 
days after 
surgery
Atelectasis 
Length of 
hospital stay until 
release
Atelectasis: lower in the 
intervention group, without 
significant difference (P=0.08) 
between groups
Length of hospital stay: shorter in 
the intervention group (without 
statistically significant data)
Jousela et 
al.[11], 1994 
CABG 30 - 15/15 CPAP vs. oxygen 
therapy
CPAP 7.4 cmH2O 
FiO2 0.3 for 8h
FiO2 0.3 for 
8h
Atelectasis
PaO2
Atelectasis: similar between 
groups
PaO2: better in the intervention 
group, with significant difference 
between groups (P<0.05) 
Lopes et al.[8], 
2008 
CABG or valve 
surgery
100 - 50/50 BiLevel vs. 
oxygen therapy 
(nasal catheter)
For 30 minutes, 
IPAP for 
generating a 
VC > 5 ml/kg 
(average value 
10±2.12 cmH2O),  
EPAP  5 cmH2O, 
and oxygen 
attached to the 
mask at 5 l/min 
or enough for 
SpO2> 95%
5 l/min PaO2
MV Time
PaO2: better in the intervention 
group, with significant difference 
(P=0.0009) between groups
MV Time: similar between 
groups, without significant 
difference (P=0.526) between 
groups
Matte et al.[3], 
2000 
CABG 96 
33,33/30
CPAP + CP 
(coughing, 
exercises, 
aerosol therapy, 
mobilization) 
or BiLevel + 
CP vs. CP + IS 
(volume)
CPAP 5 cmH2O 
(1h/3h); BiLevel 
IPAP 12 cmH2O, 
EPAP 5 cmH2O 
(1h/3h)
CP 
parameters 
not 
described;
IS 20/2 h 
Atelectasis
PaO2 
Time spent in 
the ICU
Atelectasis: less in the 
intervention group (without 
statistically significant data)
PaO2: increased in the 
intervention group, but without 
significant difference P<0.01
Time spent in the ICU: similar, 
without significant difference 
between groups
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Pulmonary Complications
Atelectasis
Six studies assessed the incidence of atelectasis[3,11,15-17,19]. 
Among them, four[3,11,15,16] were included in the meta-analysis 
(n=407). One study compared NIV associated with usual care vs. 
usual care[15]; one compared NIV associated with conventional 
physiotherapy (CP) vs. CP[16]; another compared NIV vs. oxygen 
therapy, exclusively[11]; another study, with two intervention 
groups, compared NIV/CPAP mode associated with CP vs. CP; and 
NIV/BiLevel mode associated with CP vs. CP[3]. The use of NIV in 
the postoperative period of cardiac surgery did not significantly 
reduce the risk of atelectasis (RR: 0.60, CI95% 0.28, 1.28, I-square: 
69%) (Figure 2).  
This high statistical heterogeneity can be explained by a 
study by Al Jaaly et al.[15], which presented a more favorable result 
Mazullo, et 
al.[20], 2010 
CABG, valve 
replacement,
Combined 
surgeries, 
Interatrial 
communication, 
aneurysm repair
32 - 14/18 NIV (PSV) vs. not 
described
PSV PEEP 5 
cmH2O; levels of 
PSV adjusted to 
reach a current 
volume of 5 to 8 
ml/kg; FiO2 40%, 
for 2h
 Not 
described 
ARF after 
extubation
ARF: control group presented 
higher incidence. (without 
statistically significant data)
Oikkonenet 
al.[19], 1991 
CABG 52 - 26/26 IPPB+CP (chest 
physiotherapy 
techniques) vs. 
IS (volume) + CP
Airway peak 
pressure 10 to 
15 cmH2O at 
least four times/
day, minimum 
of 10 satisfactory 
inspirations, five 
to 10 minutes 
each session
1x/day, more 
frequently, if 
necessary CP
Atelectasis
PaO2
Atelectasis: less in the 
intervention group; without 
significant difference between 
groups (P>0.1)
PaO2: similar values between 
groups on the first three days
Pinilla et al.[17], 
1990 
CABG 58 - 32/26 CPAP+ CP (chest 
physiotherapy) 
vs. oxygen 
therapy + CP
Between 5 and 
7.5 cmH2O, for 
12h
Not 
described
Atelectasis 
Hypoxemia 
(PaO2/FiO2 )
Time spent in the 
ICU
Atelectasis: not different between 
groups 
Hypoxemia (PaO2/FiO2): 
significantly improved ratio in 
the intervention group, (P<0.05), 
half an hour until 24h after 
extubation; after that,  a decrease 
could be noted in both groups
Time spent in the ICU: similar 
between groups, without 
significant difference between 
groups
Thomas et 
al.[18], 1992 
CABG 28 - 14/14 CPAP+CP  vs. 
oxygen therapy 
+ CP
5 cmH2O, for 1h Not 
described
Hypoxemia Hypoxemia: significantly reduced 
the pulmonary shunt in the 
intervention group (P=0.016)
Zarbock et 
al.[10], 2009 
CABG or 
heart valve 
replacement
468 - 
232/236
CPAP vs. 
standard 
treatmentc
10 cmH2O, for at 
least 6h
Intermittent 
CPAP for 10 
min every 
4h at 10 cm 
H2O; other 
information 
was not 
described
Hypoxemia (PaO2/
FiO2 <100)
Nosocomial 
Pneumonia
Reintubation rate 
MV Time
Time spent in the 
ICU and at the 
hospital
Hypoxemia (PaO2/FiO2<100), 
pneumonia, reintubation rate: 
lower in the intervention group, 
with significant difference 
between groups (P=0.03)
MV Time late extubation group: 
similar between groups, without 
significant difference (P>0.05)
Time spent in the ICU and at the 
hospital: similar between groups; 
without significant difference 
(P>0.05) between groups
CPAP: continuous positive airway pressure, MRS: myocardial revascularization surgery, EPAP: expiratory positive airway pressure, CP: conventional 
physiotherapy, I/C: intervention/control, BMI: body mass index, IPAP: inspiratory positive airway pressure, IPPB: intermittent positive pressure 
breathing, ARF: acute respiratory failure, IS: incentive spirometer, LLs: lower limbs, ULs: upper limbs, PaO2/FiO2: partial pressure arterial oxygen/
fraction of inspired oxygen, PEEP: Positive end-expiratory pressure, PSV: pressure support ventilation,  ICU: intensive care unit,  CV: current 
volume, NIV: noninvasive ventilation, vs.: versus; usual carea: respiratory physiotherapy, coughing exercises, IS, mobilization and nebulization 
with bronchodilator (2.5 mg of salbutamol every 6 hours), with saline solution (5 mL every 6 hours); CPb: diaphragmatic breathing exercises 
associated with active and/or active-assisted movement of the LLs and ULs, clearing maneuvers, coughing and re-expansion techniques; 
standard treatmentc: oxygen, CP, intermittent nasal CPAP and pharmacological treatment.
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to the use of NIV. One of the factors that may justify this has to 
do with the time of application of the therapy. The study applied 
the NIV for a longer period of time, and it was withdrawn when 
the patient had to eat, drink, or before if the patient could not 
tolerate the ventilation support, with average application time of 
16 hours. In the other studies, the time was shorter (8 hours after 
extubation[11], 1h every 3h, totaling 8h[3], and 2 times a day for 30 
minutes, totaling 1h[16]).
Other factors that could influence the effects of the NIV on the 
results are the ventilation parameters and type of intervention 
performed in the control group.
The other two studies[17,19], which were not included in the 
meta-analysis due to lack of data, showed that the incidence of 
atelectasis decreased at the end of the intervention with NIV, but 
it did not differ from the control groups. 
Pneumonia
Two studies[10,15] assessed this outcome (n=594). One 
study compared NIV associated to usual care vs. usual care[15]; 
and the other, NIV vs. standard treatment (oxygen therapy, CP, 
nasal intermittent CPAP for 10 min every 4h at 10 cmH2O and 
pharmacological treatment)[10]. From the analysis, we observed 
that the use of NIV did not significantly reduce the probability of 
pneumonia (RR: 0.20; CI95% 0.04; 1.16; I-square: 0%) (Figure 3).
Acute Respiratory Failure
Only one study assessed this outcome. Mazzulo Filho et 
al.[20] carried out a study with 32 patients during the immediate 
postoperative period of cardiac surgery. The patients were 
randomly divided into two groups: control (n=18) and 
Table 3. Risk of bias assessment.
Study, year 
Random 
Sequence 
Generation
Allocation 
Concealment
Blinding  
Therapist
Blinding  
Patient
Blinding of 
the Outcome 
Assessment
Description 
of Losses and 
Exclusions
Intention-to-
treat Analysis
Al Jaaly et al.[15], 2013 Yes Yes No Not informed Yes* Yes No
Franco et al.[16], 2011 Not informed Not informed Not informed Not informed Not informed Yes Yes
Jousela et al.[11], 1994 Not informed Not informed Not informed Not informed Not informed Yes Yes
Lopes et al.[8], 2008 Yes Not informed Not informed Not informed Not informed Yes Yes
Matte et al.[3], 2000 Not informed Not informed Not informed Not informed Yes* Yes No
Mazullo et al.[20], 2010 Not informed Not informed Not informed Not informed Not informed Yes No
Oikkonen et al.[19], 1991 Not informed Not informed Not informed Not informed Yes** Yes Yes
Pinilla et al.[17], 1990 Yes Not informed Not informed Not informed Yes** Yes No
Thomas et al.[18], 1992 Not informed Not informed Not informed Not informed Not informed Yes Yes
Zarbock et al.[10], 2009 Not informed Not informed Not informed Not informed Not informed Yes Yes
Yes*=for the Atelectasis outcome; Yes**= for the chest X-ray
Fig. 2 – Analysis of the atelectasis regarding the studies that compared the prophylactic NIV to the control group. NIV=noninvasive ventilation
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intervention (n=14), which received NIV/PSV mode during 2 
hours, after extubation. As to the pulmonary complication, none 
of the patients from the intervention group presented ARF; on 
the other hand, nine patients from the control group did. 
Hypoxemia 
Three studies[10,17,18] assessed this outcome. It was impossible 
to perform the meta-analysis of this outcome, because the 
studies did not present sufficient data for the analysis.
Zarbock et al.[10] performed a study with 468 patients 
that underwent elective heart surgery, and compared the 
NIV/CPAP mode vs. standard treatment (oxygen therapy, CP, 
nasal intermittent CPAP for 10 min every 4h at 10 cmH2O 
and pharmacological treatment). The study showed that the 
incidence of hypoxemia (PaO2/FiO2< 100) was lower in the 
intervention group, when compared with the control group (1 of 
232; 5 of 236 patients, respectively).
Pinilla et al.[17] carried out a study with 58 patients, and 
compared NIV/CPAP mode associated to CP vs. CP and oxygen 
therapy. They found that the PaO2/FiO2 ratio was significantly 
better in the intervention group (P<0.05), half an hour until 
24h after extubation, when compared with the control group; 
after that, it decreased in both groups (325±62, 320±37, in the 
intervention and control groups, respectively, without difference 
between groups). 
Thomas et al.[18] compared two groups with 14 patients 
after CABG, applying NIV/CPAP mode associated to CP vs. CP 
and oxygen therapy. The fraction of the pulmonary shunt was 
of 16.3% before, 12.6% during and 15.7% after the CPAP; in the 
control group, the shunt was reduced from 17.3% to 16.8%. 
This reduction was significantly higher in the CPAP group when 
compared with the control group (P=0.016). 
PaO2 
Four studies[3,8,11,19] assessed this outcome. It was not possible 
to perform the meta-analysis of this outcome, because the 
studies did not present sufficient data for the analysis.
Matte et al.[3] performed a study with 96 patients, randomly 
divided into three groups. The study assessed two intervention 
groups: one group compared NIV/CPAP mode associated to CP 
(coughing, aerosol therapy, exercises, mobilization) vs. CP, and 
the other compared NIV/BiLevel mode associated to CP vs. CP. 
In the three groups, the PaO2 (mmHg) significantly decreased 
Fig. 3 – Analysis of the pneumonia regarding the studies that compared the prophylactic NIV to the control group. NIV=noninvasive ventilation 
in the 1st day of postoperative care (preoperative: control group 
78±10, CPAP 76±12, BiLevel 81±10; 1st day before treatment: 
control group 65±12, CPAP 63±9, BiLevel 66 ±11; P<0.001). For 
the patients of the control group, this decrease was still present 
on the 2nd day; however, the patients in the intervention group 
presented a slightly improved PaO2 (P<0.01). 
Lopes et al.[8] developed a study with 100 patients that 
underwent CABG or heart valve surgery, randomly divided into 
two groups. The study applied NIV/BiLevel mode for 30 minutes 
after extubation vs. oxygen therapy. The NIV improved the PaO2, 
with significant difference (P=0.0009) between groups; the same 
happened with time, comparing the moment before extubation 
with 30, 120 and 360 minutes after the procedure (P=0.00008)[8]. 
Conversely, two studies[11,19] found different results. In a 
study performed with 30 patients that underwent CABG, who 
were randomly divided into two groups, NIV/CPAP mode vs. 
oxygen therapy, the PaO2 decreased significantly in the control 
group after extubation (from 19.2±5.3 kPa to 12.4±2.7 kPa), 
but it decreased less in the CPAP group (from 16.4±3.3 kPa to 
14.0±2.1kPa). In the 2nd PO, the PaO2 was equally low in both 
groups (control: 8.4±1.5 kPa, CPAP: 8.9±1.9 kPa)[11].
Oikkonen et al.[19] performed a study with 52 patients who 
were randomly divided into two groups: IPPB associated to CP 
vs. CP and IS. On the first three days of PO care, the values of 
PaO2 (kPa) were similar in both groups (1st PO: control 14±1, IPPB 
15±1; 2nd PO: control 12±1, IPPB 11 ± 1; 3rd PO: control 10±1, IPPB 
11±1), without statistically significant differences. Based on this, 
both resources are equally efficient.  
Reintubation Rate
Two studies assessed this outcome (n= 594)[10,15]. It was observed 
that using NIV does not significantly reduce the probability of 
reintubation (RR: 0.51; CI95%: 0.15; 1.66; I-square: 0%) (Figure 4).
Time spent in the ICU
Three studies assessed this outcome (n=641)[3,10,17]. One study 
assessed two intervention groups: one compared NIV/CPAP mode 
associated to CP vs. CP, and the other compared NIV/BiLevel mode 
associated to CP vs. CP[3]. Another study compared NIV associated 
to CP vs. oxygen therapy associated to CP[17]; and another study 
assessed NIV vs. standard treatment[10]. It was observed that using 
NIV does not significantly reduce the time spent in the ICU (-0.04 
days; CI95%: - 0.13; 0.05; I-square: 0%) (Figure 5).
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Fig. 5 – Analysis of the time spent in the intensive care unit regarding the studies that compared the prophylactic NIV to the control group. 
NIV=noninvasive ventilation
Fig. 4 – Analysis of the reintubation rate regarding the studies that compared the prophylactic NIV to the control group. NIV=noninvasive 
ventilation
Length of Hospital Stay
Only two studies assessed length of hospital stay (n=594)
[10,15], however, it was not possible to perform the meta-analysis 
due to lack of data. According to Al Jaaly et al.[15], the length of 
hospital stay until release from hospital care, in days, was shorter 
in the intervention group, when compared with the control 
group (5±1.5; 6±1.5, respectively, P=0.019). Considering only 
the doctors’ opinion, the patients could be released. However, 
because of non-medical reasons (such as social factors), the 
patients could not be released and the total length of hospital 
stay until the release was similar, without significant difference 
between groups (P=0.552). 
A study by Zarbock et al.[10] showed that the total length of 
hospital stay was similar between groups, without significant 
difference (intervention group 13±0.5 days, control group 14±0.6 
days; P>0.05). 
Mechanical Ventilation Time 
Three studies assessed this outcome (n=694)[8,10,15]; however, 
it was not possible to perform the meta-analysis due to lack of 
data.  
In the study by Lopes et al.[8], comparing NIV vs. oxygen 
therapy, the average time of mechanical ventilation was 
3.77±0.94h, with no significant difference between the control 
and intervention groups (P=0.526). Zarbock et al.[10] assessed NIV 
vs. standard treatment after admission to the ICU. The patients 
were divided into two groups: the late extubated group and the 
extubated group; after that, each group was subdivided into 
intervention and control groups. Patients in the late extubated 
group (intervention and control) were ventilated for the same 
length of time (6.2±0.5 h, 6.±0.7 h, respectively, P>0.05); data 
from the extubated group were not described. Finally, the third 
study assessed NIV associated with usual care vs. usual care, and 
the average time was 6 hours for the intervention and control 
groups[15].
DISCUSSION
Evidence Summary
The objective of this study was to search for the best 
available scientific evidence regarding the prophylactic use 
of NIV in patients during immediate postoperative care for 
cardiac surgery. Regarding the mortality rate, only one study 
assessed this outcome, and the result was similar between the 
intervention and control groups. We observed that prophylactic 
NIV, when compared to conventional physiotherapy or 
oxygen therapy, did not significantly reduce the probability 
of pulmonary complications such as atelectasis, pneumonia, 
reintubation rate and time spent in the ICU. As to the outcome 
of ARF, the incidence was higher in the control group. Regarding 
the outcome of hypoxemia, in most studies, the use of NIV 
improved oxygenation. Regarding PaO2, only half of the studies 
that assessed this outcome found that NIV improved it. As to 
the mechanical ventilation time and length of hospital stay, the 
results were similar between the groups.
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For the outcome mortality rate, study showed low incidence 
between the intervention and control groups. This can be 
explained by the fact that the patients included in the studies had 
preoperative comorbidities, and similar surgical characteristics, 
among others, without the need for emergency surgery[15]. 
However, more studies should be carried out to expand this 
information.
Another outcome assessed by our study was pulmonary 
complications. These are frequent in the PO of cardiac surgery, 
and the etiology of the dysfunction results from a multifactorial 
process, which involves surgical and preoperative factors, well 
reported in the literature[4-7]. Thus, early therapy is necessary to 
avoid further degradation[3].
From the review, it was observed that using NIV during 
the postoperative care of heart surgery did not significantly 
reduce the risk of atelectasis, but it improved oxygenation. This 
complication is often caused by a compromised ventilation lung 
perfusion ratio due to atelectasis. Even after cardiac surgery 
without complications, atelectatic areas decrease functional 
residual capacity and increase pulmonary shunt. These 
unventilated areas can account for up to 20% of the total lung 
volume, thus causing hypoxemia in the PO[10]. In this sense, NIV 
avoids alveolar collapse and enables better alveolar recruitment, 
reducing the formation of atelectasis and increasing functional 
residual capacity[10,16].
Even though NIV presents positive effects in other populations, 
such as patients with ARF in the postoperative period of abdominal 
surgery[21], in our study we have not yet found a beneficial effect of 
this intervention in relation to atelectasis. One thing that may justify 
these unfavorable outcomes are the NIV pressure parameters, with 
CPAP values between 5 and 7.5 cmH2O[3,11]. These pressures low 
in the airways have transitory effects on gas exchange[10,17]. It is 
believed that, for a prolonged effect, high pressure values are 
required to keep airways open[10]. A previous study performed 
with patients after thoracic surgery demonstrated that pressures 
of at least 9 to 10 cmH2O should be used to maintain positive 
tracheal pressure throughout the respiratory cycle[22].
Another pulmonary complication is pneumonia. From the 
analysis, it was observed that using NIV did not significantly 
reduce the probability of pneumonia[10,15]. We observed that 
there is a favorable tendency to the use of NIV; however, more 
RCTs, with larger sample sizes, are necessary to corroborate this 
information.
Regarding the outcomes of reintubation rate and time spent 
in the ICU, it was observed that using NIV does not significantly 
reduce the probability of reintubation and the time spent in 
the ICU. This may have occurred because of the small number 
of included studies (two and three, respectively). It is possible 
that with more RCTs, with larger sample sizes, this result could 
change; therefore, there is no evidence on the effectiveness of 
NIV on the reintubation rate and time spent in the ICU. 
Another assessed outcome was the length of hospital 
stay, but only two studies assessed it[10,15]. The time was similar 
between groups in both studies, with no significant difference 
between groups. This similarity can be justified by the low 
incidence of pulmonary complications in both studies, which 
could prolong this time if an increase occurred. 
The Strengths and Limitations of the Study
Regarding the strong methodological points of this study, it is 
important to point out the systematic and sensitive bibliographic 
search, with explicit and reproducible eligibility criteria, without 
restriction of language and date, independently performed by 
two assessors; as well as the selection of studies, data extraction 
and analysis of methodological quality of included articles, also 
performed independently by two assessors. In addition to that, 
a meta-analysis was performed with the results of the studies, 
provided they allowed such analysis, since the meta-analysis can 
give more reliable estimates as to the efficacy of the treatment.
As to the limitations, the low methodological quality of the 
included studies stands out, since the indispensable items for 
assessing the risk of bias were presented incompletely or not 
informed. In addition, the included studies were quite different 
regarding the physiotherapy techniques, resources and exercises 
used, time of intervention, time of application of NIV and 
frequency of examinations. All this may compromise the results 
found in the meta-analyses. 
In addition to the methodological differences, we highlight 
the small number of studies found in the literature, and the sample 
size, with small number of patients, which suggest the need for 
new RCTs with more patients and more methodological rigor.
  
CONCLUSION
Our study showed that no difference between the use of 
prophylactic NIV and conventional physiotherapy or oxygen 
therapy could be found in patients during the postoperative 
period of cardiac surgery, in relation to mortality rate and 
pulmonary complications such as atelectasis, pneumonia, 
reintubation rate, time spent in the ICU, length of hospital 
stay and mechanical ventilation time, with an improvement in 
oxygenation. Therefore, due to the low methodological rigor of 
the included articles and small sample size, new RCTs should be 
carried out to corroborate this information.
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